Clinical Trial Update: Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of a long-acting muscarinic antagonist (LAMA) and an ultra-long-acting beta-agonist (uLABA) on the methacholine dose-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma | Phase 4 | Status: COMPLETED